No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Category: MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Discover Reeva FT: Revolutionizing Wound...

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

Summus Medical Laser | Launches...

The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.

The Frax Pro System Launches

"The Frax Pro and Nordlys systems, both with Frax 1550 and Frax 1940 applicators, extend our legacy of innovation in non-ablative treatments," says Geoffrey Crouse, Chief Executive Officer of Candela.

Control 11F Mechanical Thrombectomy System Used Successfully to Remove a Large Clot

"The Control 11 French Mechanical Thrombectomy System can remove large clots," said Shawn Fojtik, President of Control Medical Technology in Park City, Utah.

CMS Approves Coding Application for PROPEL Sinus Implant: Approval Establishes New S Code for PROPEL to Facilitate Specific Coding & Payment

“CMS’s agreement, at our request, to assign separate codes to SINUVA and PROPEL reflects and supports our deliberate strategy to leverage Intersect ENT’s proprietary drug-eluting sinus stent technology platform while, at the same time, broadening our portfolio of therapeutic offerings, clinical indications, and health economic data to support evidence-based and cost-effective care across the continuum of need in chronic rhinosinusitis,” notes Thomas A. West, President and CEO of the company.

Breath Biopsy Panel for Respiratory Diseases Now Commercially Available Reports Owlstone Medical

The breath biomarker panel, which is now commercially available, is intended to support research to distinguish between different types of chronic inflammatory airway diseases including asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis, and to facilitate better therapeutic decision making and monitoring.

The Diamondback 360 Coronary Orbital Atherectomy System Receives CE Mark

Diamondback 360 Coronary Orbital atherectomy system is the market-leading coronary atherectomy device in the United States. Diamondback combines differential sanding and pulsatile forces to treat all calcium modalities, including nodular, eccentric (irregular) and concentric (ring-shaped).

The Spex LP- Lowest Profile Shapeable Reinforced Support Catheter By Reflow Medical

The Spex LP (Low Profile) 0.014 and 0.018-inch reinforced support catheters by Reflow Medical is engineered to provide the lowest profile tip for accessing and crossing the tightest and most complex lesions with a supportive system.

Noninvasive Sepsis Monitor Patent Filed by Zynex Can Provides Caregivers with Advanced Warning or Prediction of the Onset of Sepsis

Sepsis is one of the biggest problems in hospitals today. In the U.S. alone, over 1.7 million adults will develop sepsis annually with nearly 270,000 deaths as a result.

WaveWriter Alpha Spinal Cord Stimulator Systems Launches In the U.S.

WaveWriter Alpha Spinal Cord Stimulator Systems were approved by the U.S. Food and Drug Administration in December 2020 and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with failed back surgery syndrome, Complex Regional Pain Syndrome Types I and II, intractable low back pain and leg pain.

NeoDynamics Will Be Granted Another European Patent for Its Pulse Biopsy Tools

NeoDynamics notes the decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by NeoDynamics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy